First, we examined and analyzed the gene expression data on the response of ovarian cancer cells NCI-ADR-RES, OVACR-3, OVACR-4 and SK-OV-3 to ERL and LAP treatment [42], particularly in the context of dynamic changes in the NRF2 network and signalling pathway. Here, CEBPB is linked to ovarian cancer.